The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomized controlled trial

التفاصيل البيبلوغرافية
العنوان: The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomized controlled trial
المؤلفون: John, Jacob, Giri, Sidhartha, Karthikeyan, Arun S, Lata, Dipti, Jeyapaul, Shalini, Rajan, Anand K, Kumar, Nirmal, Dhanapal, Pavithra, Venkatesan, Jayalakshmi, Mani, Mohanraj, Hanusha, Janardhanan, Raman, Uma, Moses, Prabhakar D, Abraham, Asha, Bahl, Sunil, Bandyopadhyay, Ananda S, Ahmad, Mohammad, Grassly, Nicholas C, Kang, Gagandeep
المصدر: The Journal of Infectious Diseases
بيانات النشر: Oxford University Press, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Male, Immunology, Dose-Response Relationship, Immunologic, Immunization, Secondary, Antibodies, Viral, Microbiology, human challenge, Feces, Major Article, Humans, Immunity, Mucosal, Immunization Schedule, Science & Technology, poliovirus, Vaccination, Infant, inactivated vaccine, 11 Medical And Health Sciences, 06 Biological Sciences, OPEN-LABEL, Antibodies, Neutralizing, Virus Shedding, Intestines, Poliovirus Vaccine, Inactivated, Treatment Outcome, Infectious Diseases, Child, Preschool, Poliovirus Vaccine, Oral, MUCOSAL IMMUNITY, Female, INDIA, oral vaccine, Life Sciences & Biomedicine, Poliomyelitis
الوصف: Background In 2014, 2 studies showed that inactivated poliovirus vaccine (IPV) boosts intestinal immunity in children previously immunized with oral poliovirus vaccine (OPV). As a result, IPV was introduced in mass campaigns to help achieve polio eradication. Methods We conducted an open-label, randomized, controlled trial to assess the duration of the boost in intestinal immunity following a dose of IPV given to OPV-immunized children. Nine hundred healthy children in Vellore, India, aged 1–4 years were randomized (1:1:1) to receive IPV at 5 months (arm A), at enrollment (arm B), or no vaccine (arm C). The primary outcome was poliovirus shedding in stool 7 days after bivalent OPV challenge at 11 months. Results For children in arms A, B, and C, 284 (94.7%), 297 (99.0%), and 296 (98.7%), respectively, were eligible for primary per-protocol analysis. Poliovirus shedding 7 days after challenge was less prevalent in arms A and B compared with C (24.6%, 25.6%, and 36.4%, respectively; risk ratio 0.68 [95% confidence interval: 0.53–0.87] for A versus C, and 0.70 [0.55–0.90] for B versus C). Conclusions Protection against poliovirus remained elevated 6 and 11 months after an IPV boost, although at a lower level than reported at 1 month. Clinical Trials Registration CTRI/2014/09/004979.
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2425a6806e01891f74d171274b33fae9
http://hdl.handle.net/10044/1/45609
حقوق: OPEN
رقم الأكسشن: edsair.pmid.dedup....2425a6806e01891f74d171274b33fae9
قاعدة البيانات: OpenAIRE